首页 > 市场调查报告书 > 医疗设备

e保健

市场调查报告书

商品编码

1547937

全球真实世界证据解决方案市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Real World Evidence Solutions Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 172 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球真实世界证据解决方案市场需求预计将从 2023 年的 29.5 亿美元达到近 57.3 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 7.65%。

真实世界证据是在随机对照试验的背景下从现实世界收集观察资料的概念。这些资料是在常规临床实践过程中产生的，用于评估患者的结果。该记录储存在电子健康记录、行动装置、计费活动资料库等。的药物。

市场动态

真实世界证据在监测上市后安全和不良事件的医疗保健决策中发挥重要作用。医疗保健产品开发商正在使用 RWE 来支援旨在产生新治疗方法的观察研究和临床试验。不断增长的医疗保健和临床试验正在推动市场的成长。製药业正在投资该市场，透过社群媒体和电子医疗设备提供观察性研究、以患者为中心的研究活动，以提升患者体验。儘管是临床研究的主要贡献者，RWE 仍面临资料可用性、不同的 EMR 系统、品质和精确度问题以及治理问题等挑战。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对现实世界证据解决方案全球市场的每个细分市场进行包容性评估。真实世界证据解决方案产业的成长和趋势为本研究提供了整体方法。

市场区隔

真实世界证据解决方案市场报告的这一部分提供了有关国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按组件

服务
数据集
临床设定数据
索赔数据
药房数据
患者驱动的数据

按申请

药物开发与审批
医疗器材开发与审批
报销/覆盖范围和监管决策
上市后安全与不良事件监测

按最终用途

医疗保健公司
医疗保健提供者
医疗保健支付者
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲真实世界证据解决方案市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。现实世界证据解决方案市场的主要参与者包括 IQVIA、IBM、PPD Inc.、Parexel International Corporation、PerkinElmer Inc.、Icon Plc、Oracle、Syneos Health、Cegedim Health Data、Medpace Others。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：现实世界证据解决方案公司的竞争格局

真实世界证据解决方案市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
IQVIA

公司概况
公司收入
产品
最新动态

公司概况
公司收入
产品
最新动态

PPD Inc.

公司概况
公司收入
产品
最新动态

Parexel International Corporation

公司概况
公司收入
产品
最新动态

PerkinElmer Inc.

公司概况
公司收入
产品
最新动态

Icon Plc

公司概况
公司收入
产品
最新动态

Oracle

公司概况
公司收入
产品
最新动态

Syneos Health

公司概况
公司收入
产品
最新动态

Cegedim Health Data

公司概况
公司收入
产品
最新动态

Medpace Others

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11212359

The global demand for Real World Evidence Solutions Market is presumed to reach the market size of nearly USD 5.73 Billion by 2032 from USD 2.95 Billion in 2023 with a CAGR of 7.65% under the study period 2024-2032.

Real-world evidence is a concept of collecting observational data from real-world outside the context of a randomised controlled trial. The data is generated during routine clinical practice to assess the patient's outcome. The record is stored in electronic health records, mobile devices, billing activities databases, etc. The RWE play a critical role in health and clinical studies, provides a solution to the problem, understands the patient pathway to deliver the appropriate care and also analyse effects of drugs during a timespan.

MARKET DYNAMICS

Real-World Evidence plays an essential role in health care decisions to monitor postmarket safety and adverse events. Healthcare product developers are using RWE to support observational studies and clinical trial designed to generate new treatment approaches. Growing healthcare and clinical trials are driving the growth of the market. Pharmaceutical industries are investing in the market to boost patients experience by providing observational studies, patient-centred research activities through social media and selectronic medical devices. Despite being a major contributor to clinical research, RWE faces challenges such as availability of data, different EMR system, concerns about quality and precision and governance issues.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Real World Evidence Solutions. The growth and trends of Real World Evidence Solutions industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Real World Evidence Solutions market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Component

Services
Data Sets
Clinical Settings Data
Claims Data
Pharmacy Data
Patient-Powered Data

By Application

Drug Development & Approvals
Medical Device Development & Approvals
Reimbursement/Coverage & Regulatory Decision Making
Post Market Safety & Adverse Events Monitoring

By End-use

Healthcare Companies
Healthcare Providers
Healthcare Payers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Real World Evidence Solutions market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Real World Evidence Solutions market include IQVIA, IBM, PPD Inc., Parexel International Corporation, PerkinElmer Inc., Icon Plc, Oracle, Syneos Health, Cegedim Health Data, Medpace Others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. REAL WORLD EVIDENCE SOLUTIONS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Component
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET ANALYSIS BY COMPONENT

5.1. Overview By Component
5.2. Historical and Forecast Data
5.3. Analysis By Component
5.4. Services Historic and Forecast Sales By Regions
5.5. Data Sets Historic and Forecast Sales By Regions
5.6. Clinical Settings Data Historic and Forecast Sales By Regions
5.7. Claims Data Historic and Forecast Sales By Regions
5.8. Pharmacy Data Historic and Forecast Sales By Regions
5.9. Patient-Powered Data Historic and Forecast Sales By Regions

6. GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data
6.3. Analysis By Application
6.4. Drug Development & Approvals Historic and Forecast Sales By Regions
6.5. Medical Device Development & Approvals Historic and Forecast Sales By Regions
6.6. Reimbursement/Coverage & Regulatory Decision Making Historic and Forecast Sales By Regions
6.7. Post Market Safety & Adverse Events Monitoring Historic and Forecast Sales By Regions

7. GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET ANALYSIS BY END-USE

7.1. Overview By End-use
7.2. Historical and Forecast Data
7.3. Analysis By End-use
7.4. Healthcare Companies Historic and Forecast Sales By Regions
7.5. Healthcare Providers Historic and Forecast Sales By Regions
7.6. Healthcare Payers Historic and Forecast Sales By Regions
7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE REAL WORLD EVIDENCE SOLUTIONS COMPANIES

9.1. Real World Evidence Solutions Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF REAL WORLD EVIDENCE SOLUTIONS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. IQVIA
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. IBM
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. PPD Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Parexel International Corporation
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. PerkinElmer Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Icon Plc
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Oracle
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Syneos Health
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Cegedim Health Data
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Medpace Others
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Component (USD MN)
Services Market Sales By Geography (USD MN)
Data Sets Market Sales By Geography (USD MN)
Clinical Settings Data Market Sales By Geography (USD MN)
Claims Data Market Sales By Geography (USD MN)
Pharmacy Data Market Sales By Geography (USD MN)
Patient-Powered Data Market Sales By Geography (USD MN)
Analysis By Application (USD MN)
Drug Development & Approvals Market Sales By Geography (USD MN)
Medical Device Development & Approvals Market Sales By Geography (USD MN)
Reimbursement/Coverage & Regulatory Decision Making Market Sales By Geography (USD MN)
Post Market Safety & Adverse Events Monitoring Market Sales By Geography (USD MN)
Analysis By End-use (USD MN)
Healthcare Companies Market Sales By Geography (USD MN)
Healthcare Providers Market Sales By Geography (USD MN)
Healthcare Payers Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Real World Evidence Solutions Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Real World Evidence Solutions Report
Market Research Process
Market Research Methodology
Global Real World Evidence Solutions Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Component
Market Attractiveness Analysis By Application
Market Attractiveness Analysis By End-use
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Component (USD MN)
Services Market Sales By Geography (USD MN)
Data Sets Market Sales By Geography (USD MN)
Clinical Settings Data Market Sales By Geography (USD MN)
Claims Data Market Sales By Geography (USD MN)
Pharmacy Data Market Sales By Geography (USD MN)
Patient-Powered Data Market Sales By Geography (USD MN)
Global Market Analysis By Application (USD MN)
Drug Development & Approvals Market Sales By Geography (USD MN)
Medical Device Development & Approvals Market Sales By Geography (USD MN)
Reimbursement/Coverage & Regulatory Decision Making Market Sales By Geography (USD MN)
Post Market Safety & Adverse Events Monitoring Market Sales By Geography (USD MN)
Global Market Analysis By End-use (USD MN)
Healthcare Companies Market Sales By Geography (USD MN)
Healthcare Providers Market Sales By Geography (USD MN)
Healthcare Payers Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis